Member Info for ShareBag

Looking forward to figures for end June 2020 due next month. Have a feeling it will be very juicy.

A bit of cooling off is normal and expected. Don’t forget some traders played the Break Out very well On the charts. They will be gone soon. I am a lth so used to riding through the waves, allbeit sometimes very turbulent.

Everyone will have their own strategies for holding, entry snd exiting. I have added a few times and am just holding. IF the SP drops, if i get a win from one of my other sticks I will double up. They already have Tier 1 resources and If a deal does go ahead with AA it can be massive.

The board’s language was very positive in the investors call and don’t forget 2 companies have been sold previously for 260 mill and 8 bill And they had similar kind of resource. Also like the fact it was mentioned ARC minerals want the best deal possible for the shareholders. Looking forward to the further drill program data.

Very positive and that region is copper rich so just matter of finding further decent copper grades. Good luck all and hope this can change our lives. You just never know.

My buys popped up 182,980 and 291,634. The sp is being held around 4.10 it seems to fill orders. Thats my take on it.

Call in fomo. :) really haven’t for any to add now for now so ill be hoping it will hold above 4p.

Of it wasn’t for this seller the sp would be in 5’s! Will be averaging down when I can. Suppose everyone has their strategy to sell Despite the news.

If a but out happens, the amount those who hold to the end can be life changing and thats no pump. Even those with modest amounts in here. Can be transformational, not only for Arc but for investors and they only have to wait what under 5 1/2 months top side.

Exit strategy. There is no point in talking about what It should be as everyone will have their own. For me this opportunity if the deal goes ahead doesn't come too often So is worth the risk/reward but it all depends how Much you have in The first place- simply too many variables. I have 400k so not a massive amount so willing to hold as long as I can

As with other stocks. Nearly 2 Bags from lows bt not beenin since the lows. Could do well now with news to come

Have the MM’s been Told to keep in under 2p. Honestly.

My guess is 2p will be broken for good before H1 results in a month or so.

Do agree a placing is not always bad thing but in-order for it not to have a sour taste for old and new shareholders, a integumen has to prove itself to be a big revenue earner before any kind of placing. 2 mill in Q1 2020 and 1 mill in 2019 is good but needs to be in a better place in-terms of revenue to store confidence in the shareholders that Integumen is definitely a company that will be making multi millions.

Can sell well over a mill at 1.90.

Yes shares price did drop to 1p BUT you forget most others halved as-well. Yes granted the drop did start a few weeks before the cv crisis which lead to drops in the overall market but at-least be fair.

The Fundamentals here are much better than they were a few months ago. The figures for H1 should be interesting as Q1 there were 2 mill revs so lets see what Q2 generated.

What i have an issues with is why does someone who is more negative than positive Come on here spending time on a stock which he/she has supposedly sold. Was he/she even holding - i doubt it (maybe was trading it). Anyway when i sell a share or have no interest in it I haven’t got time to slate it lol. It will also go against my moral compass.

For that reason wouldn’t believe most derampers or ones that are offering a negative opinion.

Every broker will have Their pwn method So I suggest you speak to yours.

My broker states they will message everyone with ODX holdings to find out if they want these Entitles shares for 40p

Sorry they were some older notes:

? With the most recent increase in the Lab space to be completed, the total increase will be 549% taking the total to 6,000 square feet

? Guided Revenue of £1 million (unaudited) achieved for 2019

? Confirmed c£2m (half of the guided £4million revenue for 2020) confirmed orders in Q1, 2020

? EcowaterOS (Ecological Water Operating System) launched, a green-tech data management eco-system that monitors and analyses water for bacteria contamination.

Rinocloud AI remotely detects contaminated water with 99.3% accuracy in 3.37 seconds

Consortium members include Modern Water plc, Rinocloud AI, Acumen Software, Nimbus Research Centre, Cork Institute of Technology, Cellulac plc, TcBB Resource Centre

? Signed a three-year revenue-sharing, manufacturing agency agreement with Modern Water plc. The Agreement is for £1.04 million per year and is worth 40% to Integumen after costs

? The most recent placing of £1.368 million took place on 9th December 2019 at 1.5p, more for the reassurance for client’s due diligence process for Integumen to have a strong cash buffer

? Shared revenue to deliver AI data solutions across Parity plc UK NHS clients (has 150+ institutional clients). This Agreement creates an opportunity to cross-sell intelligent data management, extracting value using analytics, with a focus on proving return on investment.

The software includes full GDPR compliance with secure cloud data migration from existing legacy systems to a digital workplace through the military grade encryption "Drive4Growth" AI platform powered by Integumen's Rinodrive.

? Many products offered by Integumen including Labskin which is the only commercially available lab-grown full thickness human skin model that naturally mimics the skins microbiome. Other products are WoundPhase, STOER Cosmetics, Algzym and Rinodrive

? Labskin breakthrough made – able to clone multiple human skin swabs into many multiples of living microbiome test subjects. This will enable to test multiple clinical trial and skincare products in parallel without the need for human volunteers, making the service more commercially attractive and profitable

? Labskin human volunteer bacteria cloning service launched. This allows Integumen to enter the clinical trial, medical device sector and Research & Development, allowing Integumen to take advantage of Pharmaceutical and Cosmetic market space

? New offices opened in Cork for IT, AI infrastructure and for global sales

? Some of the clients include 10 of the top 20 Cosmetics companies in the World

? Labskin AI Infrastructure makes use of Rinocloud’s Cloud based Technology to capture, compare clinical data. Rinocloud was acquired by Integumen in April 2019

? Rinocloud offers Several service such as Open Cloud for seamless management across public and private cloud deployments, Open Web for open source software integration, Enterprise Chat, Mobile ERP to enable mobile-worki

Might be out of date by a couple months but covers most key points.

Already doing business with several top 20 Cosmetic giants offering Labskin AI. The contracts will be not just one off payment but multi product, multi year and multi contract based. Also offering Research and Development needs for these Cosmetic and Pharmaceutical giants. Margins for the Labskin service are 80%.

Integumen signs a Cooperative alliance MOU with Innocare Group, Shanghai, China. This will assist commercial enterprises in China with routes to regulatory compliance using Labskin and LabskinAI without the need for animal testing for cosmetics and skincare products.

Laboratory doubled in size in 2019 and again it should double in size again at some point in 2020. That in it self should be a clue where we are heading. That will be a 300% increase.

New offices and Digital Hub opened in Cork, Ireland for IT, AI Infrastructure support and Global Sales.

Sales team only recruited in around End of June 2019 giving only a few months to acquire contracts, Head of Enterprise Sales being Paul Ryan. CIO, Colin O'Sullivan also appointed as CIO and both having a wealth of experience.

3-year revenue sharing Framework with Parity. Integumen will be fulfilling needs for clients that need GDPR, Security, AI and Big Data, Business Tool Software and Mobile Enterprise Resource Solutions . Have access to over 150+ clients in the public and private sector.

Have a 3 year development Remote Automated Water Research project for RAWTest.

Launch of ecowaterOS for real-time water monitoring, recovery, treatment and recycling. Some consortium members include Rinocloud AI, Modern Water (MWG), Acumen Software etc. A material contribution on revenue is already expected this year with partnership with Acumen Software.

I million unaudited revenue's for 2019 already in the bag as promised and guided 4 mill for 2020. My personal view point is this may be superseded as it does not include possible Parity partnership and RAWTest revenue's going forward.

Gerard has stated that they will now grow organically. Placing on the 9th Dec 2019 raised £1.368 million as a fail safe for the clients that we have on-board as a reassurance measure.

Integumen who bought out Rinocloud (won the Tech Award 2019 in Ireland), in their own right driving their business forward and may even surpass Labskin revenue's 2:1 as mentioned by GB.

May other services/products provided like Woundcare, CBD Testing, STOER Products for Men etc.

Integumen have so far made the right moves (yes the way the placing was carried out did leave a sour taste but it nearly always does). The Labskin and Intgumen website has information which is worth a view. Do your own research but imo this company could be a monster in the making. In the right sector and already doing business with Multi Billion pound companies.

Pilgrim. Good point.

Have invested in Integumen for approx 18months and nothing has changed yet.

Its aim. Hope is needed for the majority of investments.

Confident and hope can go together but don’t waste time on my choice of words.

Moneyman. I didn’t expect fireworks from 2019 but I do expect more from H1 2020 onwards. Honeymoon period is over. I am confident going forward and the picture will become clearer (i hope)